Advertisement
Organisation › Details
Roche (Group)
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. *
Start | 1996-01-01 existent | |
Industry | pharmaceutical | |
Industry 2 | diagnostics (medical/biological) | |
Region | Basel BS | |
Country | Switzerland | |
Street | 124 Grenzacherstr. | |
City | 4070 Basel BS | |
Tel | +41-61-688-1111 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | I: 50,001 to 100,0 (2018-12-31) |
Currency | CHF | |
Annual sales | 56,846,000,000 (sales, consolidated (2018) 2018-12-31) | |
Profit | 10,865,000,000 (2018-12-31) | |
* Document for »About Section«: Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. | ||
Record changed: 2024-04-02 |
Advertisement
More documents for Roche (Group)
- [1] Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel....
- [2] NanoTemper Technologies GmbH. (5/18/22). "Press Release: NanoTemper Technologies Welcomes Andreas Schmitz as Its First Chief Human Resources Officer". Munich....
- [3] Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA....
- [4] Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo....
- [5] Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top